Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
66,399,673
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
42,379,694
-
Shares change
-
+8,074,013
-
Total reported value, excl. options
-
$973,032,101
-
Value change
-
+$189,224,828
-
Number of buys
-
60
-
Number of sells
-
28
-
Price
-
$22.96
Institutional Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q4 2019
As of 31 Dec 2019 RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) had 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 42,379,694 shares of stock of the company.
Largest 10 holders included RA CAPITAL MANAGEMENT, L.P., NEA Management Company, LLC, JANUS HENDERSON GROUP PLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), WELLINGTON MANAGEMENT GROUP LLP, BAKER BROS. ADVISORS LP, BlackRock Inc., MPM ASSET MANAGEMENT LLC, FEDERATED HERMES, INC., and PRIMECAP MANAGEMENT CO/CA/.
This table shows 89 institutional shareholders of the security as of 31 Dec 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.